Trial Profile
Randomised phase II trial of ETS 2101 [dexanabinol] in patients with glioma
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 13 Feb 2013
Price :
$35
*
At a glance
- Drugs Dexanabinol (Primary)
- Indications Glioma
- Focus Therapeutic Use
- Sponsors e-Therapeutics
- 13 Feb 2013 New trial record